CTRE vs SBRA

Key Takeaways

• CareTrust REIT (CTRE) and Sabra Health Care REIT (SBRA) are both healthcare-focused real estate investment trusts, but they diverge sharply in scale, growth strategy, and balance sheet positioning.
• CTRE has deployed approximately $1.8 billion in investments during 2025 at blended yields near 8.6%, dramatically outpacing SBRA's roughly $450 million in acquisitions over the same period.
• CTRE's net debt-to-EBITDA ratio of approximately 0.7x reflects a fortress balance sheet with substantial untapped capacity, while SBRA's leverage sits at 5.00x, closer to sector norms.
• SBRA offers a notably higher dividend yield at roughly 5.4% versus CTRE's approximately 3.6%, appealing to income-oriented investors seeking current cash flow.
• Both REITs benefit from favorable demographic tailwinds in senior housing, but CTRE's international expansion into the United Kingdom adds a diversification dimension absent from SBRA's domestic-only portfolio.
• SBRA has been actively pivoting toward managed senior housing, targeting 40% of net operating income from that segment, while CTRE remains predominantly triple-net lease-based with a broader asset mix.

Introduction

Healthcare real estate investment trusts have drawn considerable investor attention in recent months as aging demographics, rising occupancy rates, and improving rent coverage metrics converge to support the sector. Two of the most discussed names in this space — CTRE (CareTrust REIT, Inc.) and SBRA (Sabra Health Care REIT, Inc.) — offer contrasting approaches to capitalizing on these trends. This stock comparison examines how each company has performed in the current market environment, what has driven their respective trajectories, and how their business models, risk profiles, and growth engines compare. For traders and investors weighing exposure to healthcare real estate, understanding the trade-offs between these two REITs is essential for informed decision-making.

CTRE Overview and Recent Performance

CTRE, headquartered in San Clemente, California, is a self-administered REIT that owns, acquires, develops, and leases skilled nursing facilities, seniors housing, and other healthcare-related properties across 33 states and the United Kingdom. The company operates predominantly through long-term triple-net leases, a structure in which tenants bear most property-level expenses including taxes, insurance, and maintenance — thereby insulating the landlord from operational cost volatility.

In recent market activity, CTRE has been one of the standout performers in the healthcare REIT segment. The company reported full-year 2025 normalized FFO (Funds From Operations — a key REIT earnings metric) of $1.76 per share, a 17% increase over the prior year, powered by a record $1.8 billion in investment activity closed at a blended stabilized yield of 8.6%. CTRE raised approximately $1.1 billion in gross equity proceeds during 2025, including a $736 million public offering, fortifying a balance sheet that ended the year with net debt-to-EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of just 0.7x — well below its stated target range of 4.0x to 5.0x. The company entered 2026 with about $334 million in cash on hand, no borrowings on its $1.2 billion revolving credit facility, and an investment pipeline of approximately $600 million. Its strategic acquisition of UK-based Care REIT plc has diversified the portfolio internationally and reduced concentration in U.S. skilled nursing assets. For 2026, management guided to normalized FFO of $1.90 to $1.95 per share, reflecting confidence in sustained momentum.

SBRA Overview and Recent Performance

SBRA, based in Tustin, California, is a healthcare REIT that invests in skilled nursing facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Unlike CTRE's predominantly triple-net model, SBRA has been deliberately expanding its managed senior housing portfolio — properties where it retains operational upside through third-party management agreements — with a stated goal of increasing that segment's contribution to roughly 40% of total net operating income (NOI).

SBRA's recent performance reflects steady operational improvement across its portfolio. In the fourth quarter of 2025, same-property managed senior housing cash NOI rose 12.6% year-over-year, capping a year in which the quarterly average increase reached 15.0%. The company closed approximately $450 million in investments during 2025 at an average initial cash yield of about 7.5%, with an additional $240 million in awarded investments carrying into early 2026 at yields near 8.0%. SBRA also completed the disposition of seven skilled nursing facilities as it strategically rebalances toward higher-growth segments. A notable credit milestone arrived in September 2025 when Moody's upgraded SBRA's senior unsecured notes to investment-grade Baa3, citing sound operating performance and improved leverage. The company ended 2025 with net debt-to-adjusted EBITDA of 5.00x and approximately $1.2 billion in total liquidity. For 2026, SBRA introduced normalized FFO guidance of $1.49 to $1.53 per share, representing roughly 4.9% year-over-year growth at the midpoint.

Trending AI Robots

In a market environment where healthcare REIT performance can hinge on nuanced shifts in operator coverage ratios, regulatory reimbursement rates, and capital allocation decisions, many traders are turning to algorithmic tools for timely, data-driven insights. Tickeron's Trending AI Robots page features a curated selection of the platform's hundreds of AI trading bots, each designed to trade thousands of different tickers with distinct strategies, timeframes, and risk parameters. Only the bots best suited to current market conditions earn placement in this section, giving users a filtered view of top-performing algorithms. These AI-powered bots span varied trading styles — from swing trading to longer-term trend following — and are equipped with comprehensive performance statistics including win rates, trade volume, and return profiles. For investors seeking a systematic edge in stock comparison and trade timing, exploring the Trending AI Robots page may offer a useful starting point.

Head-to-Head Comparison

When comparing CTRE and SBRA, the most striking contrast lies in their balance sheet positioning and growth trajectories. CTRE operates with net debt-to-EBITDA of approximately 0.7x, giving it enormous dry powder for acquisitions without straining credit metrics. SBRA, at 5.00x leverage, sits near the upper end of sector norms and must fund new investments with a more balanced mix of debt and equity — including active use of its ATM (at-the-market) equity offering programs, which can create ongoing shareholder dilution.

On the growth front, CTRE's $1.8 billion in 2025 investments dwarf SBRA's $450 million, and CTRE's acquisition yields in the 8.6%–8.9% range exceed SBRA's 7.0%–8.2% range. This higher-yield deployment, combined with CTRE's lower share count dilution relative to capital raised, has translated into stronger per-share FFO growth — 17% in 2025 versus SBRA's more modest mid-single-digit pace. However, CTRE's triple-net-heavy model means it captures less operational upside from improving senior housing fundamentals, whereas SBRA's growing managed portfolio allows it to benefit directly from rising occupancy and room rates.

Dividend investors face a clear trade-off: SBRA's forward yield of approximately 5.4% substantially exceeds CTRE's roughly 3.6%, yet CTRE's dividend is supported by a lower payout ratio (approximately 71–76% of normalized FAD, or Funds Available for Distribution) and a far more conservative capital structure. SBRA's dividend, while well-covered at current levels, leaves less margin for error if operator performance were to deteriorate.

From a risk perspective, CTRE's international exposure to the UK care home market introduces currency and regulatory complexity absent from SBRA's exclusively domestic portfolio. Conversely, SBRA's managed senior housing segment carries operational risk — property-level performance can fluctuate with labor costs and local competition — whereas CTRE's triple-net leases provide highly predictable cash flows. On market sentiment, both stocks have posted strong 2026 returns, with CTRE up roughly 22% year-to-date and SBRA gaining approximately 21%, though CTRE trades at a lower P/E (price-to-earnings) multiple of about 27x versus SBRA's roughly 35x on a trailing basis.

Tickeron AI Verdict

Based on observable trend consistency, balance sheet quality, and relative positioning, Tickeron's AI-driven analysis would likely favor CTRE in the current environment. The company's combination of ultra-low leverage, a $600 million replenished investment pipeline, higher acquisition yields, and 17% FFO-per-share growth offers a clearer path to compounding shareholder value without the dilution headwinds or credit constraints that SBRA must navigate. CTRE's triple-net model provides earnings visibility that algorithmic models tend to reward, while its significant under-levered capacity creates optionality for accretive capital deployment that SBRA, operating near its leverage ceiling, cannot match. That said, SBRA's pivot toward managed senior housing positions it to capture meaningful operational upside if occupancy and rate trends continue improving — a catalyst that could narrow the performance gap. The AI verdict is probabilistic rather than definitive: CTRE currently exhibits a stronger confluence of momentum, stability, and growth capacity, while SBRA offers a higher income component and an evolving strategic narrative that warrants continued monitoring.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations